Insights On Manufacturing Logistics

  1. How The Tariffs Could Impact Your Drug Development Supply Chain 4/16/2025

    Explore how a fully integrated, U.S.-based supply chain strategy can help you navigate potential tariff risks, reduce complexity, and strengthen resilience in pharmaceutical development.

  2. Forget About Isolators: Switching From Manual Vial To Automated Bag Filling 4/11/2025

    Discover how transitioning from manual vial filling to single-use bag systems can reduce contamination risk, improve accuracy, and enhance GMP compliance in biopharmaceutical manufacturing.

  3. Friendshoring: A Strategic Shift In Pharma Supply Chains 4/11/2025

    To safeguard the consistent delivery of essential therapies to patients around the world, biopharmaceutical companies, alongside their CDMO partners, are rethinking traditional supply models and seeking more resilient, forward-looking strategies.

  4. Integration Of Container Closure Integrity In Contract Manufacturing 3/28/2025

    Maintaining drug product sterility and compliance demands rigorous Container Closure Integrity (CCI) within contract manufacturing. Learn how to fortify your processes.

  5. Managing Risks In Injectable Drug Delivery 3/13/2025

    Gain insights pertinent to efficient and effective drug development. Understand and execute a risked-based critical thinking approach related to injectable drug packaging and delivery.

  6. Small Volume ATMP Cryo-Freezing Strategies 3/11/2025

    Discover best practices for cryopreserving small-volume ATMPs, focusing on sterility, viability, and efficiency with advanced containers and packaging.

  7. Human Factors Testing: Engaging End-Users In Med Device Development 3/11/2025

    Explore the significance of human factors in the development of medical devices through an illustration of how important it is to incorporate the end users in the device development process.

  8. ATMP Cryopreservation Done Right - Best Practice In Small Volume Cryo-Freezing 3/11/2025

    Explore best practices for cryopreserving small-volume advanced therapy medicinal products (ATMPs), emphasizing sterility, cell viability, and efficiency using innovative single-use systems and aseptic connectors.

  9. FAQs On The Revised EU GMP Annex 1: Volume 2 3/5/2025

    Review the implementation of a holistic Contamination Control Strategy (CCS). Discover four key considerations for assessing component readiness: product, process, protection, and proof.

  10. Streamlining Compliance With Pre-Clinical Safety Tests 3/4/2025

    As cell therapies advance, challenges in ensuring safe, scalable, and compliant production increase. Discover how to develop efficient strategies to maintain cell viability and functionality throughout the supply chain.